Bruker Enters Functional Single-Cell Biology Research Solutions With PhenomeX Acquisition
Portfolio Pulse from Vandana Singh
Bruker Corporation (BRKR) has agreed to acquire PhenomeX Inc (CELL) for $1.00 per share in an all-cash transaction, valuing PhenomeX at approximately $108 million. PhenomeX, a functional cell biology company, was formed through the combination of Berkeley Lights and IsoPlexis. The transaction is expected to close in Q4 2023.
August 17, 2023 | 4:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bruker Corporation is acquiring PhenomeX Inc, which could potentially expand its product portfolio and market reach.
The acquisition of PhenomeX by Bruker Corporation could potentially expand Bruker's product portfolio and market reach, which could positively impact its stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
PhenomeX Inc is being acquired by Bruker Corporation, which could result in a significant increase in its stock price.
The acquisition of PhenomeX by Bruker Corporation could result in a significant increase in PhenomeX's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100